Ignite Creation Date:
2024-05-05 @ 5:20 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00430898
Status:
COMPLETED
Last Update Posted:
2008-12-18
First Post:
2007-01-31
Brief Title:
Basiliximab in Moderate to Severe Ulcerative Colitis
Sponsor:
Cerimon Pharmaceuticals
Organization:
Cerimon Pharmaceuticals
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Ulcerative Colitis |
Keywords:
| Name | View |
|---|---|
| ulcerative colitis basiliximab | View |